An Outstanding ‘Mini’ Traverse of Katahdin for Damon Runyon Cancer Research

The Timmerman Traverse for Damon Runyon Cancer Research Foundation had a spectacular experience on Mt. Katahdin in Maine on Saturday.

Weather was glorious. Fall colors were vibrant. The team was fit and mentally ready for rocky, rugged terrain. They got a rich outdoor experience with a steep rock scramble on Cathedral Path, then crossing Katahdin’s famous Knife Edge ridge.

This trip represents an iteration of the Timmerman Traverse. Expect more of this type of outing in 2026. Many are expressing interest in shorter trips closer to home, but that still combine giving and community building. I’m listening. 

My vision is to explore trails for the Timmerman Traverse in naturally beautiful places in Washington, Colorado, Wyoming, Maine, New Hampshire, British Columbia and the Eastern Sierras of California. 

These trips are about getting out in nature. Doing hard things. Making friends. Supporting good causes.

This work strengthens community. 

Please enjoy a few photos from a memorable day on Mt. Katahdin, Oct. 4, 2025.

Want to participate or sponsor in 2026? luke@timmermanreport.com. 

Participants on Katahdin 2025:

• Luke Timmerman, founder & editor, Timmerman Report
• Doug Fambrough, founder, portfolio manager, KCap Biotech Fund; former CEO, Dicerna Pharmaceuticals
• John Keilty, venture partner, Third Rock Ventures
• Anna French, managing partner, Qiming Venture Partners USA
• Judith Hasko, partner, co-chair of life sciences, WilmerHale
• Art Krieg, founder & CEO, Zola Therapeutics
• Lalo Flores, venture partner, Scion Life Sciences
• Vineeta Agarwala, general partner, A16Z Bio & Health Fund
• Expery Omollo, postdoctoral researcher, MIT; Robert A. Swanson Family Fellow, Damon Runyon Cancer Research Foundation
• Henry Kilgore, postdoctoral researcher, Whitehead Institute; Damon Runyon Cancer Research Foundation Fellow
• Antonio LaPorte, postdoctoral researcher, Harvard University; Damon Runyon Research Foundation Fellow.